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Long terminal repeat (LTR) sequences are important determinants of mink cell focus-forming (MCF) murine leukemia virus
pathogenesis. These sequences include the enhancer and sequences between the enhancer and promoter (DEN). In a
previous study we showed that a virus missing the DEN region in its LTR was severely attenuated in its ability to induce
thymic lymphoma. In this study we observed that a virus with an LTR consisting of DEN but no enhancer sequences was
pathogenic. We compared the pathogenicity of this DEN virus with other LTR mutant MCF13 viruses that contained a single
enhancer (1R) or a single enhancer plus DEN (1R 1 DEN). All LTR mutant viruses generated thymic lymphoma, however, at
a much lower incidence and with a longer latency compared with wild-type (WT) MCF13 virus. DEN virus replication in the
thymus was the lowest compared with the 1R and 1R 1 DEN viruses. Viral replication in a different thymic subpopulation
could not explain the decreased pathogenicity of the LTR mutant viruses compared with WT virus. However, lower levels of
mutant virus replication in the thymus compared with WT during the preleukemic period may contribute to the attenuation
of pathogenicity. The phenotype of tumors induced by the mutant viruses was similar and differed from tumors induced by
WT virus by the presence of CD32CD42CD82 cells. Analysis of LTR sequences of infectious virus rescued from tumors
induced by the 1R and 1R 1 DEN viruses showed that amplification of enhancer sequences had occurred during tumor
development. The lack of DEN virus expression by tumor cells led us to propose that DEN sequences may play a role at an
early step in tumorigenesis. © 2001 Academic Press
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It has been shown that retroviral long terminal repeats
(LTRs) contain important determinants of viral pathoge-
nicity (Golemis et al., 1989; Hallberg et al., 1991; Hanecak
et al., 1991; Ishimoto et al., 1987; Li et al., 1987; Speck et
al., 1990a). These LTR elements are especially critical for
the pathogenic properties of replication competent ret-
roviruses with simple genomes. The mechanism of cel-
lular transformation used by retroviruses which lack an
oncogene is that of insertional mutagenesis. By this type
of mechanism, cellular protooncogenes are activated by
the LTRs of proviruses which have integrated adjacent to
them (Corcoran et al., 1984; Cuypers et al., 1984; Hay-
ward et al., 1981; Payne et al., 1982). Because activation
of these protooncogenes results in their aberrant tran-
scription, an essential step in tumorigenesis, the LTR
elements that regulate transcription have been intensely
studied (Boral et al., 1989; Golemis et al., 1989; Hallberg
t al., 1991; Hanecak et al., 1991; Ishimoto et al., 1987;
aimins et al., 1984; Li et al., 1987; LoSardo et al., 1990;
Pantginis et al., 1997; Speck et al., 1990a,c; Thornell et al.,
1 To whom correspondence and reprint requests should be ad-
ressed at Department of Immunology and Microbiology, Wayne State
niversity, 540 E. Canfield Ave., Detroit, MI 48201. Fax: (313) 577-1155.
-mail: fyoshi@med.wayne.edu.
1211988; Tupper et al., 1992). In addition, some of these LTR
elements have been shown to affect the ability of a
retrovirus to replicate in a particular tissue or cell type
(Athas et al., 1995; Yoshimura et al., 1999), functioning
most likely by controlling the transcription of the inte-
grated provirus.
The most well-studied LTR element that regulates
transcription in a cell-type-specific manner is the en-
hancer, which usually comprises tandemly repeated se-
quences (Coffin et al., 1997). LTRs which contain a single
enhancer repeat or mutated enhancers have reduced
levels of transcriptional activation, and their viruses are
significantly attenuated in pathogenicity (Davis et al.,
1985; Hallberg et al., 1991; Holland et al., 1989; Martiney
et al., 1999; Nieves et al., 1997; Speck et al., 1990b;
Zaiman et al., 1998). LTR elements, which are located
downstream of the enhancer, have been identified to
also be important for transcriptional activation and viral
pathogenicity (Hanecak et al., 1991; Tupper et al., 1992;
Yoshimura et al., 1999). We have identified a 96-bp region
between the enhancer and promoter (DEN for down-
stream of enhancer), which affects the ability of the mink
cell focus-forming 13 (MCF13) murine leukemia virus
(MLV) to replicate in the thymus and induce thymic lym-
phoma (Tupper et al., 1992; Yoshimura et al., 1999). De-
letion of this region of the MCF13 LTR resulted in a
significant increase in latency and decrease in incidence
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122 YOSHIMURA AND WANGof disease. We, furthermore, demonstrated that DEN is
the only region of the LTR that regulates transcription in
activated T cells (Chen and Yoshimura, 1994) and that the
NF-kB protein-binding site in DEN is primarily responsi-
ble for this activation (Yoshimura et al., 1997).
Because of the importance of the DEN region for
transcriptional activation specifically in T cells and its
role in MCF13 pathogenicity, we wished to determine
whether a virus with an LTR comprising DEN with no
enhancer sequences was tumorigenic. In this study we
observed that such a mutated MCF13 virus was able to
induce thymic tumors, albeit at a reduced level com-
pared with the wild-type virus. However, in comparing
the pathogenicity of this virus with that of LTR mutants
which lacked an enhancer repeat or the DEN region, we
observed that all of these mutant viruses had similar
disease latency and incidence. To better understand
how each of these LTR elements contributes to retroviral
tumorigenesis, we have compared the ability of these
mutant viruses to replicate in the thymus during the
preleukemic period and in thymic tumors.
RESULTS
Construction of MCF13 MLVs containing mutated
LTRs
We previously demonstrated that the DEN region of
the MCF13 LTR made a significant contribution to the
ability of this retrovirus to induce thymic lymphoma (Tup-
per et al., 1992). Deletion of DEN from the LTR of the viral
genome resulted in a longer mean latency and a signif-
icantly reduced incidence of disease compared with the
wild-type (WT) virus. We, furthermore, observed by tran-
sient expression assays that only the sequences in DEN
but not in the enhancer were able to potentiate transcrip-
tion in activated T cells (Chen and Yoshimura, 1994). To
better understand the contribution of DEN to viral patho-
genicity, we determined whether an MCF13 mutant virus
which retained DEN, but no other known transactivating
LTR sequences (DEN virus), could induce disease. For
comparison with another major element in the LTR which
controls transcription, we examined the pathogenicity of
an MCF13 virus that contains one of the enhancer re-
peats but no DEN sequences in its LTR (1R virus). Finally,
to determine whether there may be potential interactions
between these two transcriptional regulatory elements
for the pathogenicity of MCF13, we also examined a virus
with an LTR containing both 1R and DEN (1R 1 DEN
virus).
To perform these studies we constructed a mutant
MCF13 virus in which the 69-bp direct repeats, which
constitute the enhancer region of the LTR, were entirely
deleted (DEN, Fig. 1). Deletion of the enhancer repeats
was accomplished by site-directed mutagenesis of a
plasmid clone of MCF13 which contained a single LTR
(Yoshimura, 1982). The correct mutation was verified byDNA sequence analysis. Infectious virus was prepared
by transfection of ligated linear DNA into Mus dunni
cells.
For the mutant MCF13 viruses which contained either
a single 69-bp enhancer element in its LTR (1R, Fig. 1) or
a single enhancer and DEN (1R 1 DEN, Fig. 1), we used
viruses that we previously constructed and tested (Tup-
per et al., 1992). Although the pathogenicity of the 1R and
1R 1 DEN mutant viruses was previously characterized
(Tupper et al., 1992), we reexamined them in this study
for direct comparison with the newly synthesized DEN
virus. In this study we also performed characterizations
of the 1R and 1R 1 DEN mutant viruses that were not
done before.
Ability of MCF13 viruses with deletions in the LTR to
induce thymic lymphoma
Comparable amounts of infectious units (106 IFU) of
MCF13 wild-type virus or each of the different viruses
with mutated LTRs were inoculated into neonatal AKR/J
mice. Mice were monitored for disease development for
185 days, at which time spontaneous lymphomas begin
to occur in AKR mice (Nowinski and Hays, 1978). As
shown in Fig. 2, the DEN virus was able to induce thymic
lymphoma, although at a significantly reduced incidence
and increased latency compared with WT virus. The
mean latency for the DEN virus was 166 days compared
with 102 days for the WT virus (Table 1).
The only type of disease produced by all of the viruses
with mutated LTRs was thymic lymphoma, similar to the
WT MCF13 virus. Furthermore, the pathogenic properties
of the mutated viruses were similar regardless of
whether the LTR consisted mainly of DEN, 1R, or 1R 1
DEN (Table 1). Thus, the DEN region is comparable to
one enhancer repeat with respect to viral pathogenicity.
This result was surprising because of the importance
that the enhancer has been shown to play in the ability of
different murine leukemia viruses to induce disease.
DEN virus replication in the thymus
Because of our surprising observation of the lym-
phomagenicity of the DEN virus, we characterized its
ability to replicate in the thymus. We wished to determine
whether differences in replication in this organ from WT
virus could contribute to the reduced pathogenicity of the
DEN virus. For this analysis we assessed the percentage
of thymic lymphocytes which were infected with either
virus by detecting the cell surface expression of the
MCF13 envelope glycoprotein (gp70) and performing in-
fectious center assays (Fig. 3). To detect MCF13 glyco-
protein expression, we performed an indirect immuno-
fluorescence assay with a primary monoclonal antibody
(MAb 514), which is specific for MCF glycoproteins
(Chesebro et al., 1983), and a secondary FITC-labeled
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123ROLE OF THE LTR DEN REGION IN MCF MLV PATHOGENESISgoat anti-mouse IgG. Stained cells were detected by flow
cytometry.
At 6 and 10 weeks postinoculation (p.i.) we were un-
able to detect any gp70-positive (gp701) cells above
ackground levels for the DEN virus (Fig. 3A), although
T virus was detectable at these time points (data not
hown). It was not until 12 weeks p.i. that we were able
o detect virus-infected thymic cells. At this time point a
ean of 19% of thymic lymphocytes were gp701. These
esults were in contrast with WT virus replication, which
e examined in a previous study, when we first detected
CF13-infected thymus cells as early as 3 weeks p.i.
Yoshimura et al., 1999). Moreover, at 8 weeks p.i., the
atest time we assessed WT virus replication during the
releukemic period, 58% of thymic cells were positive for
p70 expression (Yoshimura et al., 1999). Thus, replica-
ion of the DEN virus in the thymus is considerably
ompromised compared with the WT virus, and this most
ikely contributes to its reduced pathogenicity. Although
e did not perform a time-course study of the replication
f the 1R and 1R 1 DEN viruses, our assessment of
p701 thymic cells of these mutant viruses at 12 weeks
FIG. 1. LTRs of WT, DEN, 1R, and 1R 1 DEN MCF13 viruses. Large bo
CAAT and TATA boxes are also shown. The horizontal arrow indicates t
Numbers identify nucleotides in the 600-bp WT LTR.xes identify each 69-bp enhancer repeat (1R) and the 93-bp DEN region. Thep.i. showed that both viruses replicated in the thymus
much better than the DEN virus and nearly as well as WTFIG. 2. Time course of the percentage of mice developing thymic
lymphoma after inoculation with WT, DEN, 1R, or 1R 1 DEN MCF13
virus. Neonatal AKR/J mice were inoculated intraperitoneally with 106infectious units of each virus. Symbols: , WT; M, DEN; L, 1R; and E,
1R 1 DEN.
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124 YOSHIMURA AND WANG(Table 2). We observed that 54 and 58% of thymic cells
were infected with 1R or 1R 1 DEN, respectively. The
relatively high levels of gp701 cells for these viruses
ere a surprising result because the latency and inci-
ence of tumor development of 1R and 1R 1 DEN vi-
uses were similar to the DEN virus.
To assess the percentage of thymic lymphocytes that
ere producing infectious virus, we performed infectious
enter assays at 10 and 12 weeks p.i. Similar to our gp70
nalysis, it was not until 12 weeks p.i. that we began to
etect the production of infectious DEN virus (Fig. 3B). At
his time after virus inoculation, we observed that only 2%
f the thymic cells produced infectious DEN virus (Table
). In contrast, 38% of the cells produced infectious WT
irus, and 10 and 8% of the cells produced infectious 1R
nd 1R 1 DEN virus, respectively. Thus, although all
hree mutant viruses produced lower levels of infectious
CF13 compared with WT, virus production was the
owest for the DEN virus. These data corroborated the
esults of our gp70 analysis.
TABLE 1
Lymphomagenicity of WT and Mutant MCF13 Viruses
Virus
No. of mice
inoculated
Disease
incidence (%)a
Avg latency 6 SD
(days)b
WT 29 93 102 6 4.1
EN 31 32 166 6 17
R 30 30 157 6 17
R 1 DEN 15 20 139 6 22
a Percentage of inoculated animals that developed thymic lym-
homa.
b Calculated from animals with thymic lymphoma when necropsied.
FIG. 3. Percentage of virus-infected thymic lymphocytes after DEN v
MCF13 envelope gp70 at various weeks postinoculation (p.i.) of virus.
analyzed by flow cytometry as described under Materials and Metho
described under Materials and Methods. Each data point corresponds to
horizontal bar.Because of the low level of DEN virus infection in the
hymus by the infectious center assay, we also examined
pleen and bone marrow to test the possibility that the
EN virus may replicate better in other hematopoietic
rgans. Compared with virus replication in the thymus,
ll four viruses replicated poorly in spleen and bone
arrow where infectious virus was detectable at approx-
mately 100-fold less than in the thymus. However, the
one marrow was the only organ in which the levels of
nfectious virus produced by all three mutant viruses
ere similar. Nevertheless, virus levels in the bone mar-
culation into AKR/J neonates. (A) Thymic lymphocytes expressing the
lymphocytes (106) were stained with the MCF-specific MAb 514 and
Infectious center assays of thymic lymphocytes were performed as
TABLE 2
Thymic Lymphocytes Infected with WT or LTR
Mutant MCF13 Viruses
Virus % gp701a
No. infectious centers per
5 3 104 cellsb
Thymus Spleen Bone marrow
WT 72.9 6 10.8 19,150 (38)c 150 (0.3) 135 (0.3)
DEN 19.1 6 17.7 835 (2) 20 (0.04) 15 (0.03)
1R 54.1 6 4.9 5040 (10) 65 (0.1) 25 (0.05)
1R 1 DEN 57.5 6 4.1 4100 (8) 30 (0.06) 20 (0.04)
Control 4.7 6 1.0 0 0 0
a Values are means 6 standard deviations of the percentages of
thymic lymphocytes that expressed gp70 on the cell surface at 12-week
after inoculation of virus.
b Number of cells producing infectious virus calculated for 5 3 104
cells. Collected cells (1 3 102 to 5 3 104) were plated onto M. dunni
ibroblasts, and virus infection was assessed by an indirect immuno-
luorescence focus assay as described under Materials and Methods.
wenty to 150 foci per plate were counted.
c Number in parentheses corresponds to percentage of cells pro-
ducing infectious virus.irus ino
Thymic
ds. (B)an individual mouse. Mean percentage values are indicated by the
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125ROLE OF THE LTR DEN REGION IN MCF MLV PATHOGENESISrow were approximately 5- to 10-fold lower compared
with the WT virus (Table 2). Thus, although the DEN virus
replicated poorly compared with the other three viruses,
especially WT, it replicated best in the thymus.
Subpopulations of thymic cells infected with the
viruses containing mutated LTRs
To determine whether the decreased replication in the
thymus of the DEN virus compared with the WT, 1R, and
1R 1 DEN viruses could be the result of its replication in
different thymic subpopulation, we identified the cell
ype in which replication occurred for these viruses.
irus-infected thymic cells were identified at 12 weeks
.i. by multiparametric flow cytometry. For this analysis,
irus-infected cells were identified by staining with the
onoclonal antibody MAb 514 and followed with a sec-
ndary FITC-conjugated goat anti-mouse IgG antibody.
hese cells were then costained with fluorescence-la-
eled antibodies to the CD3, CD4, and CD8 cell surface
ntigens, which distinguish five major subpopulations of
hymic T cells, which are the immature CD32CD42CD82,
D32CD41CD81, and CD31CD41CD81 cells, and the
ore mature CD31CD41CD82 and CD31CD42CD81
cells (Table 3) (Fowlkes and Pardoll, 1989; Rothenberg,
1992; Scollay, 1991). For this analysis, we first selected
thymic lymphocytes that expressed MCF13 gp70 with
the Paint-a-Gate software. Subsequently, we calcu-
lated the percentage of the selected gp701 cells rep-
esented by each subpopulation of thymic lympho-
ytes. Our results showed that the percentage of thy-
ic subpopulations which comprised the virus-
nfected cells was very similar for the WT, DEN, 1R,
nd 1R 1 DEN viruses. These virus-infected cells
ere mainly of the CD31CD41CD81, CD32CD41CD81,
and CD31CD41CD82 subpopulations. Thus, we con-
cluded from this analysis that all four viruses repli-
cated in the same thymic subpopulations and that
T
Subpopulations of Select
Virus
gp
CD32CD42CD82 CD32CD41CD81
WT 0.8 6 0.6 7.6 6 5.0
DEN 0.5 6 0.3 7.0 6 4.4
1R 0.7 6 0.2 8.6 6 2.5
1R 1 DEN 0.8 6 0.4 9.8 6 3.0
a Values are means 6 standard deviations of the percentages of se
hymuses from four to nine mice, which were inoculated with either th
eeks p.i.replication in different subsets was not responsible for
their different levels of replication in the thymus.Phenotype of thymic lymphoma induced by the
viruses containing mutated LTRs
In a previous study we observed that the WT MCF13
virus produced thymic tumors with heterogeneous phe-
notypes (Yoshimura et al., 1999). However, the thymic cell
type which was present in all WT-induced tumors was
CD31CD41CD81, and in the majority of these tumors,
this was the predominant cell type. To determine
whether the mutated viruses, which infected subpopula-
tions of thymic cells similar to the WT virus, would pro-
duce tumors resembling those generated by WT, we
characterized the phenotype of tumors induced by the
mutant viruses (Table 4). Our characterization of tumors
induced by these mutant viruses showed that the tumor
phenotypes were similar to those produced by WT virus
with the exception of the CD32CD42CD82 population.
This subpopulation constituted less than 1% of WT tumor
cells (Yoshimura et al., 1999), but represented a signifi-
cant percentage of cells in many tumors induced by the
mutant viruses.
Characterization of viruses that were rescued from
thymic tumors induced by the mutant MCF13 viruses
Because the viruses we examined in this study con-
tained LTRs with deletions of important transcriptional
regulatory sequences, it was possible that additional
changes in the LTRs were required for these viruses to
induce thymic tumors. To determine whether changes,
such as insertions and duplications, had occurred for the
LTR mutant viruses, we isolated viruses from thymic
tumors that were induced by the DEN, 1R, and 1R 1 DEN
viruses. We subsequently characterized the LTRs of the
viruses that were rescued from tumors.
To isolate infectious virus from tumor cells, we cocul-
tivated these cells with M. dunni fibroblasts, which do not
possess genomic sequences related to MCF MLVs
(Lander and Chattopadhyay, 1984). We have observed
that all three mutant viruses are equally infectious for
01 Thymic Lymphocytes
mic subpopulation (%)a
D31CD41CD81 CD31CD42CD81 CD31CD41CD82
72.7 6 7.5 1.7 6 0.8 13.3 6 2.2
78.9 6 2.1 1.5 6 1.6 9.9 6 2.5
78.9 6 2.7 1.4 6 0.5 7.5 6 0.9
76.8 6 6.4 1.5 6 0.6 8.0 6 2.1
gp701 thymic lymphocytes represented by the T-cell subpopulations.
DEN, 1R, or 1R 1 DEN MCF13 virus, were individually analyzed at 12ABLE 3
ed gp7
701 thy
C
lectedthese cells. Virus infection was monitored by staining
cocultivated M. dunni cells with the MCF glycoprotein-
ymic tu
r tant vir
126 YOSHIMURA AND WANGspecific MAb 514 or MAb 83A25, which recognizes gly-
coproteins of a broad range of MLVs, including eco-
tropic, polytropic, xenotropic, and amphotropic viruses
(Evans et al., 1990). We subsequently isolated cellular
DNA from infected M. dunni cells and amplified the
proviral LTR sequences by PCR. Multiple PCR products
were cloned into the pCR2.1-TOPO plasmid vector (In-
vitrogen) prior to DNA sequencing.
For the DEN mutant, we were unable to detect any
evidence for virus infection of the M. dunni indicator cells
when they were stained with MAb 514. To determine
whether non-MCF viruses could be rescued from these
tumors, we subsequently stained the cocultivated cells
with MAb 83A25. M. dunni cells, which were cocultivated
with cells from all tumors induced by the DEN virus that
were examined, stained positive with this antibody. Se-
quence analysis of PCR products of proviral LTRs indi-
cated that none of the tumors induced by the DEN virus
produced this virus or other viruses with MCF13 LTR
sequences. Instead, all of the tumors produced viruses
containing LTRs with sequences of either the Akv eco-
tropic or Bxv-1 xenotropic virus (Hoggan et al., 1986;
Massey et al., 1990). Rescue of the ecotropic Akv virus
was not surprising since it is expressed at high levels in
the AKR mouse thymus (Kawashima et al., 1976; Rowe
and Pincus, 1972). All of the Akv LTRs contained a single
enhancer. We were able to distinguish between the
Bxv-1 and MCF13 LTR because of two nucleotide differ-
ences between their LTR sequences (Massey et al.,
1990; Stoye et al., 1991; Yoshimura et al., 1985). Three of
the tumors also produced viruses with LTRs which con-
tained altered Bxv-1 enhancer and DEN sequences, in-
dicating that recombination had occurred between Bxv-1
FIG. 4. Identification of changes in the LTRs of viruses isolated from th
epresent different LTR elements present in the inoculated MCF13 muLTRs. Thus, none of the tumors induced by the DEN virus
was able to produce this virus.Our analysis of the LTRs of viruses rescued from three
different tumors induced by the 1R virus showed that one
of them did not produce any virus related to 1R, a second
tumor (12) produced a 1R virus without any changes, and
a third tumor (13) produced a virus which contained two
tandem partial enhancer sequences, which were miss-
ing different portions of the enhancer (Fig. 4). In addition,
the Akv virus, which was rescued from the DEN-induced
lymphomas, was rescued from all three 1R-induced tu-
mors. Only rescued viruses that were related to the
inoculated mutant MCF13 virus are shown in Fig. 4.
Two of five tumors that were induced by the 1R 1 DEN
virus (18 and 21, Fig. 4) produced infectious 1R 1 DEN
with no changes in the LTR. The virus rescued from
tumor 17 contained a hybrid LTR with the 1R region from
MCF13 but the DEN region from Akv, indicating recom-
bination between 1R 1 DEN and Akv. Tumor 25 pro-
duced an infectious virus that contained an insertion of a
complete 1R sequence upstream of the 1R and DEN
regions (Fig. 4). Tumor 15 produced only the Akv virus,
which was also produced by tumor 25.
DISCUSSION
Our data indicate that MCF13 viruses with LTRs that
contain the DEN region but no enhancer sequences are
able to induce thymic lymphoma. However, the DEN
virus is attenuated in both incidence and latency com-
pared with the wild-type virus. Assessment of DEN virus
replication in the thymus suggested that lower levels of
virus replication in thymic lymphocytes contributed to the
attenuation of tumorigenesis. We observed that MCF13
viruses with LTRs that contained a single enhancer but
mors induced by the DEN, 1R, or 1R 1 DEN virus in AKR/J mice. Boxes
uses. Acquired sequences are shown by shaded areas.no DEN sequences (1R) or a single enhancer plus DEN
(1R 1 DEN) were also reduced in pathogenicity with
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127ROLE OF THE LTR DEN REGION IN MCF MLV PATHOGENESISincidence rates and latencies similar with the DEN virus.
However, the latency period for the 1R 1 DEN virus was
slightly shorter than either 1R or DEN, which suggested
some weak synergism between these two LTR elements.
The levels of thymic replication of the 1R and 1R 1
DEN viruses were greater than the DEN virus as as-
sessed by gp70 envelope expression and infectious cen-
ter assays. This was surprising because disease latency
and incidence were not greatly different for all three
mutant viruses. A possible explanation for this observa-
tion is that the DEN virus replicates as well as the 1R and
1R 1 DEN viruses only in a specific thymic cell type,
hich eventually becomes transformed into a thymic
umor. We could not have detected such a cell because
ur analysis of virus-infected cells by gp70 expression
nd infectious center assays included the entire popu-
ation of thymic cells.
Our observation that the DEN virus could replicate as
ell as the 1R and 1R 1 DEN virus in the bone marrow
ould support the idea that MCF replication in the bone
arrow, rather than the thymus, is more predictive of
ymphoma development. This hypothesis is supported by
ork of other investigators on viral pathogenesis in the
KR mouse and Moloney (Mo) MLV, which also induces
hymic tumors. By transplantation assays it has been
hown that bone marrow but not thymic cells from young
KR mice have the potential to develop into overt T-cell
ymphoma (Haran-Ghera, 1980; Haran-Ghera et al.,
T
Phenotypes of Thymic Lymphomas
Virus Lymphoma CD32CD42CD82 CD32CD41
DEN 1 2.6 19.2
2 12.8 9.6
3 3.5 17.4
4 6.7 10.6
5 8.9 6.9
6 10.3 20.1
7 8.0 1.3
8 3.8 2.1
9 10.0 1.6
R 1 2.5 0.8
2 3.4 1.9
3 32.7 0.7
4 3.4 0.4
5 4.4 19.6
6 10.6 11.6
R 1 DEN 1 5.7 6.6
2 6.0 5.4
3 3.9 15.4
4 19.2 2.1
a T-cell phenotype of cells isolated from individual thymic lymphoma987). Furthermore, the laboratory of H. Fan has shown
hat Mo MLV infection of bone marrow osteoclasts and
t
Dmall presumptive hematopoietic cells occurs before in-
ection of thymic lymphocytes, leading them to propose
hat the first site of virus infection is the bone marrow
Okimoto and Fan, 1999). This idea, however, requires
urther testing to substantiate it as a critical step in
CF13 pathogenesis.
Our analysis of thymic cell subpopulations which are
nfected by WT and LTR mutant MCF13 viruses has
ndicated that all of the viruses replicate in the same cell
ype. Thus, differences in virus replication in different
hymic subpopulations do not explain the variation in
athogenicity we observed for the mutant viruses com-
ared with each other and the WT virus. These results
nd those we obtained in an earlier study in which we
xamined other types of LTR mutations support the idea
hat the thymic cell type which is targeted for MCF13
nfection is more dependent upon its expression of the
CF receptor (Battini et al., 1999; Tailor et al., 1999; Yang
t al., 1999), rather than transcription factors that trans-
ctivate either the enhancer or the DEN sequences. On
he other hand, these transcriptional transactivators can
ffect the level of virus expression once infection has
ccurred.
We rescued infectious virus from thymic tumors in-
uced by the mutant viruses to examine whether
hanges in the LTRs of the inoculated viruses had oc-
urred during the course of tumor formation. We were
nable to rescue any MCF13-related virus by cocultiva-
ed by Viruses with Mutated LTRsa
mor cells in thymic subpopulation
CD31CD41CD81 CD31CD42CD81 CD31CD41CD82
63.3 1.8 7.2
36.4 7.0 17.5
62.7 2.5 7.7
39.4 5.9 28.0
52.3 0.9 25.9
58.3 1.1 6.6
82.2 2.2 5.3
88.9 0.1 4.1
48.3 36.2 1.2
26.3 1.6 62.9
50.1 22.8 10.1
54.0 3.8 5.6
91.7 0.1 3.9
70.9 2.3 0.9
39.0 6.3 18.3
30.3 47.8 0.9
28.3 5.5 42.3
63.1 9.3 2.3
30.2 24.4 0.8
ced by DEN, 1R, or 1R 1 DEN MCF13 virus.ABLE 4
Produc
% of tu
CD81ion experiments from thymic lymphomas induced by the
EN virus. Sequence analysis of the LTRs of rescued
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128 YOSHIMURA AND WANGvirus indicated that the only infectious viruses produced
by these tumor cells were the ecotropic Akv and xeno-
tropic Bxv-1 endogenous viruses. Both are parental en-
dogenous viruses involved in the production of polytropic
MCF MLVs (Chattopadhyay et al., 1981; Massey et al.,
1990; Quint et al., 1984; Stoye et al., 1991), and have been
hown previously to be produced by AKR thymic cells
nd murine lymphomas (Kawashima et al., 1976; Massey
t al., 1990; Rowe and Pincus, 1972). Thus, it appears that
equences in the DEN region are insufficient for tran-
criptional activation of the integrated proviruses in tu-
or cells. At what stage during tumorigenesis DEN virus
eplication shuts down is not known, although replication
as detectable in various hematopoietic organs at 12
eeks postinoculation. Whether insertion or amplifica-
ion of sequences in the DEN LTR is required for proviral
ctivation of cellular protooncogenes is not known. We
ave not been successful in isolating DEN proviruses
hat have integrated adjacent to the c-myc oncogene as
e previously did for the 1R virus (Chen and Yoshimura,
994). Our inability to do so for the DEN virus may
uggest that DEN sequences are involved in transcrip-
ional activation of a different protooncogene(s).
MCF13-related viruses were rescuable from tumors
nduced by both the 1R and 1R 1 DEN viruses (Fig. 4).
ne of the tumors induced by the 1R virus produced a
irus containing two tandem partial MCF13 enhancer
equences (tumor 13, Fig. 4). Amplification of a single
nhancer sequence may be required for efficient c-myc
ctivation. This notion is supported by an earlier study in
hich we observed that 1R proviruses adjacent to c-myc
solated from tumor DNA had partially or completely
uplicated 1R sequences. A similar amplification of en-
ancer sequences was observed for an infectious virus
rom a 1R 1 DEN-induced lymphoma (tumor 25). How-
ver, enhancer amplification may not be required for this
TR mutant as two other independent isolates had no
hanges in the LTR. Isolation of 1R 1 DEN proviruses
ntegrated adjacent to cellular protooncogenes would be
equired to determine whether enhancer amplification is
equired for transcriptional activation.
Our observations demonstrate that enhancer se-
uences alone are able to activate transcription of inte-
rated proviruses in thymic lymphocytes, which in turn
llow MCF replication in these cells. However, our de-
ection of a 1R virus (Fig. 4) as well as proviruses adja-
ent to c-myc with duplicated enhancer sequences
Chen and Yoshimura, 1994) would suggest that multiple
nhancers are more potent than single enhancers in
ctivating transcription. This proposal is supported by
ther studies in which it was observed that an MCF virus
ith two enhancer repeats replicated much better in the
hymus than a virus with a single enhancer (Holland et
l., 1989) and that amplification of enhancer sequences
ccurred in SL3–3 proviruses integrated adjacent to c-
yc (Morrison et al., 1995). Our rescue of 1R 1 DENiruses without additional amplification of these se-
uences in the majority of cases suggests that these LTR
egions together suffice for efficient transcriptional acti-
ation. However, our inability to rescue any DEN viruses
rom tumors (Chen and Yoshimura, 1994) suggests that
EN sequences alone are not sufficient for effective
ranscriptional activation of integrated proviruses. This
bservation would suggest that DEN sequences play a
ole at an early step in tumorigenesis, possibly activating
rotooncogenes required for tumor initiation rather than
rogression. Virus-infected thymic cells at this earlier
tep may have transcription factors which are able to
ind sequences in DEN, such as Ets (Yoshimura et al.,
997), but these factors are missing in end-stage lym-
homa cells.
MATERIALS AND METHODS
onstruction and isolation of the DEN mutant virus
A plasmid containing a clone of the wild-type MCF13
LV (PMSL) (Tupper et al., 1992; Yoshimura, 1982) was
sed to delete the enhancer repeats. Deletion of these
equences was performed by site-directed mutagenesis
Amersham). The enhancer deletion was verified by DNA
equencing (Center for Molecular Medicine and Genet-
cs DNA Sequencing Facility at Wayne State University).
wenty micrograms of purified plasmid DNA correspond-
ng to the virus construct missing the enhancer repeat in
he LTR (DEN virus) was transfected with 33 mg of Lipo-
fectin reagent (GIBCO BRL) into M. dunni fibroblasts.
Transfected cells were passaged at high density until
100% of the cells were infected by virus as determined by
an immunofluorescence focus assay (Sitbon et al., 1985;
Tupper et al., 1992). For this assay, we used a monoclo-
nal antibody, MAb 514, which reacts specifically with
MCF glycoproteins (Chesebro et al., 1983). This mono-
clonal antibody was a generous gift of L. H. Evans, Rocky
Mountain Laboratories, Hamilton, MT. Cells on the cul-
ture dish were stained with 0.5 ml of MAb 514 superna-
tant, followed with 1 ml of fluorescein isothiocyanate
(FITC)-conjugated goat anti-mouse immunoglobulin G
(IgG) (Sigma). Both incubations were performed for 30
min at 37°C. Fluorescent foci were detected with a Nikon
phase-contrast 2 fluorescence microscope.
Viral supernatants were harvested from cell cultures,
centrifuged to remove cells, and frozen at 270°C for
assays of virus titers and injection into mice. Virus titers
were determined by infecting M. dunni cells at various
dilutions and performing focal immunofluorescence as-
says on infected cells as described above.
Inoculation of mice
Neonatal (1- to 4-day old) AKR mice were injected
intraperitoneally with 50 ml of inoculum containing 1 3
106 infectious units (IFUs) of wild-type or each mutant
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129ROLE OF THE LTR DEN REGION IN MCF MLV PATHOGENESISMCF13 virus. Control mice were inoculated with tissue
culture medium. Necropsy was performed on moribund
mice. Animals with the diagnosis of thymic lymphoma
showed a massive enlargement of the thymus with fu-
sion of thymic lobes. In most mice, there was also en-
largement of liver, spleen, and peripheral lymph nodes.
Isolation of thymic lymphocytes and infectious center
assays
Single-cell suspensions of thymic lymphocytes were
prepared by pressing thymus tissue through a wire mesh
into RPMI plus 2% inactivated fetal calf serum (IFCS).
Splenic lymphocytes were prepared similarly, followed
by lysis of reticulocytes by treatment with 0.15 mM
NH4Cl, 1 mM KHCO3, 0.1 mM EDTA (pH 7.4). Bone mar-
ow cells were prepared by flushing-out mouse femurs
ith 5 ml RPMI and 2% IFCS followed by reticulocyte
ysis. Cells were washed once with medium without
erum. Between 1 3 102 and 5 3 104 cells collected from
thymus, spleen, and bone marrow were plated in the
presence of 2 mg per ml Polybrene onto M. dunni fibro-
blasts, which had been seeded onto 60-mm-diameter
culture dishes the day before. After overnight incubation,
the medium was changed and cultures were incubated
until the cell layer was confluent, whereupon immunoflu-
orescent focus assays were performed. Between 20 to
150 foci per plate were counted.
Cell staining
Thymic lymphocytes (1 3 106) were washed twice
with phosphate-buffered saline (PBS) containing 1%
bovine serum albumin (BSA) and 0.02% sodium azide.
Washed cells were incubated with 100 ml of MAb 514
on ice for 30 min, after which time 100 ml of the
econdary antibody (FITC-conjugated goat anti-mouse
gG) at a 1:100 dilution was added. After washing twice
ith PBS, the cells were resuspended in 100 ml of PBS
ontaining hamster anti-CD3 antibody conjugated to
hycoerythrin (PE), rat anti-CD4 antibody conjugated
o Cy-Chrome, rat anti-CD8 antibody conjugated to
iotin (PharMingen), and NeutraLite avidin conjugated
o Cascade blue (CB, Molecular Probes) at dilutions
reviously determined by titration assays. Washed
ells were resuspended in 0.7 ml of 0.5% paraformal-
ehyde and analyzed by flow cytometry.
low cytometric analysis
Flow cytometry was performed on a FACS Vantage
low cytometer equipped with a HP 9000 computer run-
ing the LYSYS II software [Becton–Dickinson Immuno-
ytometry Systems (BDIS), San Jose, CA]. All data pre-
ented were based on analysis of 2 3 104 cells with thePaint-A-Gate software (BDIS). Analysis gates were set on
isotype controls.Rescue of mutant viruses and PCR amplification of
their LTRs
Thymic tumor cells (1 3 105) were plated onto M. dunni
ibroblasts in the presence of 2 mg per ml Polybrene.
After overnight incubation, the medium was changed,
and the cells were passaged at high density every other
day for approximately 3 weeks. Infected cells were
tested for virus infectivity by the indirect immunofluores-
cence assay described above. When 100% of the cells
were virus-infected by this assay, cellular DNA was pre-
pared by treating trypsinized cells with 100 mg/ml pro-
teinase K at 55°C for 1 h. Cell lysates were then boiled
for 10 min and stored at 4°C.
Proviral LTR sequences were amplified by PCR with
primers which detected MCF13 sequences (LTR 59-GC-
CATTTTGCAAGGCATGG and LTR 39-TATCGGATGACTG-
GCGCG). PCR conditions consisted of an initial treat-
ment at 95°C for 2 min, followed by 30 cycles of 95°C for
1 min, 65°C for 1.5 min, and 72°C for 1 min. The PCR
amplicons were either directly sequenced when there
was a single product or cloned into the pCR2.1-TOPO
vector (Invitrogen) before DNA sequencing when there
were multiple products.
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